You are here

Media Coverage

June 24, 2018
The Mercury News

The Mercury News tells the story of college student Delaney Van Riper who suffers from a progressive neurological disorder. She is participating in a pioneering research study led by Bruce Conklin with the hope of overcoming her condition through the use of the gene-editing technology CRISPR.

June 21, 2018
The New York Times

A recent study suggests viruses might be involved in Alzheimer’s disease. An expert in the field, Lennart Mucke noted to The New York Times, “there have been many speculations that infections contribute to the development of Alzheimer’s. None of them has held up after rigorous cause-effect evaluations.”

May 14, 2018
CBS Pittsburgh

CBS Pittsburgh’s local news program highlights Yadong Huang’s different approach to tackling Alzheimer’s disease and explains his game-changing discovery for correcting the deformed structure of a gene called apoE4.

May 14, 2018
Best Life

In its list of the most newsworthy stories of the year thus far, BestLife includes—at number 8—the recent Alzheimer’s research findings by Yadong Huang and his team.

May 5, 2018
CBS San Francisco

An original report by KPIX, the San Francisco Bay Area’s CBS station, features Yadong Huang’s work on Alzheimer’s disease. It explains how he may have found a fix for a major genetic risk factor linked to this devastating malady.

April 24, 2018
NIH Director's Blog

In a recent post on the NIH Director’s Blog, Francis Collins shares his enthusiasm about the new deep learning approach developed by Steve Finkbeiner and his partners at Google AI.

April 12, 2018
Google AI Blog

The computer scientists who collaborated with Steve Finkbeiner to develop a deep learning approach called “in silico labeling” share the discovery in this Google Research Blog post.

April 10, 2018

In this editor’s pick, Forbes highlights Yadong Huang’s recent study and describes how his team identified that a key genetic variant associated with the development of Alzheimer’s operates differently in mice and humans.

March 20, 2018

After 20 years of hope, promise, and controversy, human embryonic stem cells are reshaping biological concepts and starting to move into the clinic. This Nature editorial traces back to the discovery of induced pluripotent stem cells by Shinya Yamanaka in 2006.

March 9, 2018
WBEZ Chicago

The Nerdette podcast from WBEZ Chicago featured Bruce Conklin’s work, which uses CRISPR technology to study and find treatments for genetic diseases. In this case, it could be used to help the reporter cure her rare degenerative eye disease.